Louise Unwin
OncoMark (Ireland)(IE)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Genomics and Phylogenetic Studies, Bacterial Infections and Vaccines, Computational Drug Discovery Methods, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica(2003)1,034 cited
- → The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome(2006)885 cited
- → Sequence of Plasmodium falciparum chromosomes 1, 3–9 and 13(2002)203 cited
- → Meningococcal Genetic Variation Mechanisms Viewed through Comparative Analysis of Serogroup C Strain FAM18(2007)199 cited
- → Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma(2011)15 cited
- → High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients(2015)14 cited
- → Abstract A114: Preclinical evaluation of the PARP inhibitor olaparib in homologous recombination deficient (HRD) MRE11 mutant microsatellite instable (MSI) colorectal cancer(2009)6 cited
- → Abstract A119: A proteomics-based approach to identify biomarker profiles of homologous recombination deficiency (HRD) in breast cancer cell lines(2009)2 cited
- → Abstract 23: Low incidence of BRAFV600E mutation among melanoma patients in Ireland.(2013)1 cited
- → Abstract 3497: Identifying pre-clinical predictive biomarkers for the PARP inhibitor olaparib(2010)1 cited